Results 171 to 180 of about 23,300,046 (306)
Optimizing patient flow logistics: strategic challenges, tactical solutions, and future directions. [PDF]
Zamani H, Parvaresh F, Isfahani MN.
europepmc +1 more source
Spatial biology in cancer epigenetics
Spatial epigenomics combines molecular profiling with tissue architecture to reveal how gene regulation is organized within intact tissues. In cancer, these technologies uncover the mechanisms driving tumor heterogeneity and microenvironmental interactions, opening new opportunities for biomarker discovery and precision medicine.
Eva Crespo‐García, Manel Esteller
wiley +1 more source
Data-driven modelling of IRCU patient flow during the COVID-19 pandemic. [PDF]
Navas-Ortega AC +4 more
europepmc +1 more source
Cerebral Blood Flow in a Patient with Hemiballism
Maeda, Kengo, Sugihara, Yoshiko
openaire +3 more sources
The cell‐autonomous roles of interferon type 1 vary based on duration and intensity. While acute, robust signaling results in cancer cell cytotoxic effects, sustained, low‐level signaling is associated with tumor‐promoting effects. This review summarizes current research of IFN‐1 in cancer and within the clinical setting, with an emphasis on female ...
Ashlyn Conant +7 more
wiley +1 more source
Daily Dispo Documentation Improves Patient Flow and Discharge Efficiency. [PDF]
Bechir G.
europepmc +1 more source
Tumour heterogeneity and clonal evolution of metastatic salivary gland cancer were evaluated in two patients with adenoid carcinoma and one patient with myoepithelial carcinoma. Radiology‐guided autopsy enabled multi‐region sampling (total samples n = 149), followed by whole‐genome sequencing and phylogenetic reconstruction (17 tumour samples, 4–7 per ...
Gerben Lassche +10 more
wiley +1 more source
Supply-demand governance of hierarchical healthcare systems: mobile big data unveils non-random patient flow patterns and the bypass premium in cities. [PDF]
Guo Q, Ren H, Shao X.
europepmc +1 more source
This study identifies somatostatin receptor 4 (Sstr4) as a critical tumor suppressor against skin and head/neck cancers (HNSCC, cSCC, and BCC). The loss of Sstr4 removes a check on cell growth, causing hyperactivation of the MAPK‐ERK signaling pathway (↑).
Ali Taqvi +6 more
wiley +1 more source

